Jingfeng Pharmaceuticals (000908.SZ) securities abbreviation changed to "Shiyao Jingfeng"

17:17 01/07/2026

Jingfeng Pharmaceuticals (000908.SZ) announced that due to the completion of the company's restructuring plan, changes have occurred in the controlling shareholder and actual controller. In order to unify the brand image and promote the company's continued healthy development, the company has accordingly changed its name. The company completed the industrial and commercial registration change matters in April 2026. The company's stock abbreviation will be changed from "Jingfeng Pharmaceuticals" to "Shiyao Jingfeng", and the new stock abbreviation will be effective from July 2, 2026.

Jingfeng Pharmaceuticals (000908.SZ) announced that, as the company's restructuring plan has been completed, there have been changes in the controlling shareholder and actual controller. In order to unify the brand image and promote the company's sustainable development, the company has therefore made appropriate changes to its name. The company completed the industrial and commercial registration changes in April 2026. The company's securities abbreviation is planned to be changed from "Jingfeng Pharmaceuticals" to "Shiyao Jingfeng", with the new abbreviation set to be effective on July 2, 2026.

Shanghai Yizhong Pharmaceutical (688091.SH) plans to repurchase company shares worth 30 million to 50 million yuan.

KEEP (03650) granted 9.0584 million restricted share units.

CRTG (00269) releases annual performance figures, with a net profit attributable to shareholders of HK$661 million, turning a loss into a profit year-on-year.

Shanghai Yizhong Pharmaceutical (688091.SH) plans to repurchase company shares worth 30 million to 50 million yuan.

KEEP (03650) granted 9.0584 million restricted share units.

CRTG (00269) releases annual performance figures, with a net profit attributable to shareholders of HK$661 million, turning a loss into a profit year-on-year.